OGT Using Protein Array Platform to Develop Prostate Cancer Test, Plans Clinical Study

Oxford Gene Technology has identified a panel of biomarkers it claims can be used to distinguish individuals with prostate cancer from both normal individuals and those suffering from other diseases of the prostate.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.